Morgan Stanley Income Securities Inc. (ICB) Trades at $18.00 After Triangle; Stratos Wealth Partners LTD Cut By $750,901 Its Novartis A G (NVS) Stake

November 14, 2017 - By Winifred Garcia

Stratos Wealth Partners Ltd decreased Novartis A G (NVS) stake by 18.49% reported in 2017Q2 SEC filing. Stratos Wealth Partners Ltd sold 9,047 shares as Novartis A G (NVS)’s stock rose 4.17%. The Stratos Wealth Partners Ltd holds 39,884 shares with $3.33M value, down from 48,931 last quarter. Novartis A G now has $217.39B valuation. The stock rose 0.19% or $0.16 reaching $82.87. About 527,364 shares traded. Novartis AG (ADR) (NYSE:NVS) has risen 7.67% since November 14, 2016 and is uptrending. It has underperformed by 9.03% the S&P500.

Morgan Stanley Income Securities Inc. (ICB) formed triangle with $16.56 target or 8.00% below today’s $18.00 share price. Morgan Stanley Income Securities Inc. (ICB) has $161.34M valuation. About 840 shares traded. Morgan Stanley Income Securities Inc. (NYSE:ICB) has risen 0.67% since November 14, 2016 and is uptrending. It has underperformed by 16.03% the S&P500.

Stratos Wealth Partners Ltd increased Vanguard Index Fds (VOO) stake by 22,484 shares to 327,259 valued at $72.67 million in 2017Q2. It also upped Powershares Etf Trust (PRF) stake by 8,910 shares and now owns 19,320 shares. Ford Mtr Co Del (NYSE:F) was raised too.

Among 15 analysts covering Novartis Ag (NYSE:NVS), 5 have Buy rating, 3 Sell and 7 Hold. Therefore 33% are positive. Novartis Ag had 33 analyst reports since July 28, 2015 according to SRatingsIntel. The rating was maintained by JP Morgan with “Neutral” on Friday, March 24. The firm has “Underperform” rating given on Tuesday, April 12 by Morgan Stanley. The firm has “Hold” rating given on Monday, July 10 by Cowen & Co. The firm has “Hold” rating by Cowen & Co given on Friday, October 13. The stock of Novartis AG (ADR) (NYSE:NVS) earned “Hold” rating by Cowen & Co on Tuesday, July 18. Barclays Capital upgraded the stock to “Hold” rating in Friday, June 23 report. The firm has “Hold” rating by Cowen & Co given on Wednesday, August 9. As per Thursday, June 22, the company rating was maintained by Leerink Swann. Leerink Swann maintained it with “Market Perform” rating and $91 target in Monday, October 23 report. The rating was downgraded by Citigroup on Tuesday, March 29 to “Neutral”.

Analysts await Novartis AG (ADR) (NYSE:NVS) to report earnings on January, 24. They expect $1.16 earnings per share, up 3.57% or $0.04 from last year’s $1.12 per share. NVS’s profit will be $3.04 billion for 17.86 P/E if the $1.16 EPS becomes a reality. After $1.29 actual earnings per share reported by Novartis AG (ADR) for the previous quarter, Wall Street now forecasts -10.08% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>